Business

Merck buys B-cell disease drug for up to $1.3 billion




Merck has struck a deal worth up to $1.3 billion to buy an experimental drug that targets B-cell-related diseases.

News7f

News 7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button